<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p45" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_45{left:130px;bottom:1195px;letter-spacing:0.23px;}
#t2_45{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_45{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_45{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_45{left:238px;bottom:1061px;letter-spacing:-0.01px;}
#t6_45{left:238px;bottom:1042px;letter-spacing:-0.01px;}
#t7_45{left:238px;bottom:1022px;letter-spacing:-0.01px;}
#t8_45{left:238px;bottom:1003px;letter-spacing:-0.01px;}
#t9_45{left:128px;bottom:910px;letter-spacing:0.16px;}
#ta_45{left:238px;bottom:911px;letter-spacing:-0.2px;}
#tb_45{left:258px;bottom:882px;letter-spacing:-0.1px;}
#tc_45{left:141px;bottom:846px;letter-spacing:-0.1px;}
#td_45{left:248px;bottom:846px;letter-spacing:-0.01px;}
#te_45{left:143px;bottom:790px;letter-spacing:-0.29px;}
#tf_45{left:250px;bottom:810px;letter-spacing:-0.01px;}
#tg_45{left:248px;bottom:755px;letter-spacing:0.09px;}
#th_45{left:238px;bottom:695px;letter-spacing:-0.01px;}
#ti_45{left:238px;bottom:675px;letter-spacing:-0.01px;}
#tj_45{left:238px;bottom:641px;letter-spacing:-0.01px;}
#tk_45{left:238px;bottom:621px;letter-spacing:-0.01px;}
#tl_45{left:238px;bottom:602px;letter-spacing:-0.01px;}
#tm_45{left:238px;bottom:548px;letter-spacing:-0.01px;}
#tn_45{left:238px;bottom:528px;letter-spacing:-0.01px;}
#to_45{left:238px;bottom:509px;letter-spacing:-0.01px;}
#tp_45{left:238px;bottom:489px;letter-spacing:-0.01px;}
#tq_45{left:238px;bottom:470px;letter-spacing:-0.01px;}
#tr_45{left:238px;bottom:451px;letter-spacing:-0.01px;}
#ts_45{left:238px;bottom:431px;letter-spacing:-0.01px;}
#tt_45{left:238px;bottom:412px;letter-spacing:-0.01px;}
#tu_45{left:238px;bottom:392px;letter-spacing:-0.01px;}
#tv_45{left:238px;bottom:373px;letter-spacing:-0.01px;}
#tw_45{left:238px;bottom:353px;letter-spacing:-0.01px;}
#tx_45{left:238px;bottom:334px;letter-spacing:-0.01px;}
#ty_45{left:238px;bottom:314px;letter-spacing:-0.01px;}
#tz_45{left:238px;bottom:295px;letter-spacing:-0.01px;}
#t10_45{left:238px;bottom:276px;letter-spacing:-0.01px;}
#t11_45{left:238px;bottom:256px;letter-spacing:-0.01px;}
#t12_45{left:238px;bottom:237px;letter-spacing:-0.01px;}
#t13_45{left:238px;bottom:217px;letter-spacing:-0.01px;}
#t14_45{left:238px;bottom:198px;letter-spacing:-0.01px;}
#t15_45{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_45{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_45{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_45{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_45{font-size:21px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_45{font-size:17px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_45{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
.s6_45{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s7_45{font-size:9px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts45" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg45Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg45" style="-webkit-user-select: none;"><object width="908" height="1286" data="45/45.svg" type="image/svg+xml" id="pdf45" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_45" class="t s0_45">6.4. Panendoscopy to exclude secondary carcinomas </span><span id="t2_45" class="t s1_45">45 </span>
<span id="t3_45" class="t s2_45">FDG-PET-CT plays a role in the follow-up of node-positive patients who have undergone </span>
<span id="t4_45" class="t s2_45">primary combined radio-chemotherapy. </span>
<span id="t5_45" class="t s2_45">In general, however, the value of PET-CT is controversial. Mehanna et al. [114] found that </span>
<span id="t6_45" class="t s2_45">survival rates were comparable between patients who underwent PET-CT surveillance and those </span>
<span id="t7_45" class="t s2_45">who underwent elective neck dissection. PET-CT surveillance resulted in a considerably lower </span>
<span id="t8_45" class="t s2_45">rate of surgery (54 vs. 221). Quality of life was considered to be the same in both groups. </span>
<span id="t9_45" class="t s3_45">6.4. </span><span id="ta_45" class="t s3_45">Panendoscopy to exclude </span>
<span id="tb_45" class="t s4_45">Secondary carcinomas </span>
<span id="tc_45" class="t s5_45">6.7. </span><span id="td_45" class="t s2_45">Consensus-based recommendation </span>
<span id="te_45" class="t s6_45">EEC </span>
<span id="tf_45" class="t s2_45">Panendoscopy should be performed in patients with laryngeal carcinoma. </span>
<span id="tg_45" class="t s7_45">Consensus: 95% </span>
<span id="th_45" class="t s2_45">Panendoscopy includes esophagoscopy, tracheobronchoscopy, pharyngoscopy, </span>
<span id="ti_45" class="t s2_45">microlaryngoscopy and inspection of the oral cavity. </span>
<span id="tj_45" class="t s2_45">The information on the frequency of clinically occult secondary carcinomas varies considerably </span>
<span id="tk_45" class="t s2_45">in the literature, from 1% to over 10%. There are indications that the frequency of secondary </span>
<span id="tl_45" class="t s2_45">carcinomas depends on the stage of the primary tumor. </span>
<span id="tm_45" class="t s2_45">In patients suffering from laryngeal carcinoma, particularly those who smoke and regularly </span>
<span id="tn_45" class="t s2_45">drink large amounts of alcohol, there is a probability that these noxious substances have also </span>
<span id="to_45" class="t s2_45">caused carcinomas or their precursor lesions in other regions of the upper respiratory and </span>
<span id="tp_45" class="t s2_45">digestive tract. The extent of this probability varies greatly in the literature [125-131]. Secondary </span>
<span id="tq_45" class="t s2_45">carcinomas can occur synchronously or metachronously. Synchronous secondary carcinomas </span>
<span id="tr_45" class="t s2_45">can be clinically noticeable during the ENT examination at the time of the manifestation of the </span>
<span id="ts_45" class="t s2_45">laryngeal carcinoma, or they can be identified by the specific symptoms. Panendoscopy is </span>
<span id="tt_45" class="t s2_45">suitable for excluding or detecting clinically occult secondary carcinomas and their precursors. </span>
<span id="tu_45" class="t s2_45">It is therefore one of the diagnostic measures that is usually carried out before a therapeutic </span>
<span id="tv_45" class="t s2_45">decision is made for a histologically proven laryngeal carcinoma. The information on the </span>
<span id="tw_45" class="t s2_45">frequency of clinically occult secondary carcinomas varies considerably in the literature, from </span>
<span id="tx_45" class="t s2_45">1% to over 10%. There are indications that the frequency of secondary carcinomas depends on </span>
<span id="ty_45" class="t s2_45">the stage of the primary tumor. In principle, the majority of experts agree, based on the </span>
<span id="tz_45" class="t s2_45">publications, that panendoscopy should generally be performed as part of the staging process, </span>
<span id="t10_45" class="t s2_45">except for stage I glotis carcinomas, but especially in patients with special risk factors such as </span>
<span id="t11_45" class="t s2_45">tobacco smoke and/or excessive alcohol consumption, as well as in patients with a higher tumor </span>
<span id="t12_45" class="t s2_45">stage. If panendoscopy is recommended, it should include the entire upper respiratory and </span>
<span id="t13_45" class="t s2_45">digestive tract, except for the nose and nasopharynx, i.e. the entire oral cavity, the entire </span>
<span id="t14_45" class="t s2_45">oropharynx and hypopharynx are examined. </span>
<span id="t15_45" class="t s0_45">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
